German group, BAYER, has sold off its 6.6% stake in the US bio-tech firm, MILLENIUM PHARMACEUTICALS for more than USD 300 million. The group has thus sold off en masse almost 19.8 million in shares to CSFB-CREDIT SUISSE FIRST BOSTON with a view to a re-sale.